Price
No data yet.
Social Signal Score
Analyst Ratings
16 analystsRevenue
$1.44B+542.37%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- John C. Rademacher
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 7,397
- Beta
- 0.58
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 3.88
Financials
Revenue
$1.44B+542.4%Net Income
$53.91MEBITDA
$106.39M+3662.0%Free Cash Flow
$192.64MEPS (diluted)
$0.35Shares Outstanding (diluted)
155.77M+442.6%Operating Expenses
$161.11MCash & Debt
$193.77MReturn of Capital
$153.01MRevenue by Segment (annual)
$5.65BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.65B | $207.59M | $1.28 |
| 2024 | $5.00B | $211.82M | $1.23 |
| 2023 | $4.30B | $267.09M | $1.49 |
| 2022 | $3.94B | $150.56M | $0.83 |
| 2021 | $3.44B | $139.90M | $0.78 |
| 2020 | $3.03B | $-8.08M | $-0.04 |
| 2019 | $2.31B | $-75.92M | $-0.49 |
| 2018 | $1.94B | $-6.12M | $-1.62 |
| 2017 | $817.19M | $-64.20M | $-2.02 |
| 2016 | $935.59M | $-42.77M | $-1.77 |
| 2015 | $982.22M | $-300.13M | $-17.45 |
| 2014 | $922.65M | $-147.47M | $-8.61 |
| 2013 | $696.47M | $-69.65M | $-4.32 |
| 2012 | $593.45M | $64.71M | $4.60 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from OPCH's reported EPS growth of -9.4% a year over 13 years.
- EPS in 5 years
- $0.78
- Implied price
- $19.54
- Return from $31.13
- -8.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $9.72 — -68.8% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 17 | 21 | 25 | 29 | 33 |
|---|---|---|---|---|---|
| -19.4% | -25.0% | -21.7% | -18.9% | -16.5% | -14.3% |
| -14.4% | -20.3% | -16.9% | -13.9% | -11.3% | -9.0% |
| -9.4% | -15.7% | -12.0% | -8.9% | -6.1% | -3.7% |
| -4.4% | -11.0% | -7.2% | -3.9% | -1.0% | 1.6% |
| 0.6% | -6.3% | -2.3% | 1.2% | 4.2% | 6.9% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
52+3.33%Social Signal Score
Mentions (16)
- News (RSS)zerohedge·3h ago·Neutral
"Escape Valve" No More: San Francisco Moves To End School Choice Lottery "Escape Valve" No More: San Francisco Moves To End School Choice Lottery Authored by Lear Zhou via The Epoch Times, The San Francisco Unified School District (SFUD) board passed a resolution on Oct. 13 to replace the current lottery-based admission policy with a neighborhood-based system for elementary schools. Board members voted 5-2 to develop a policy under which every student would be assigned to a neighborhood school b
View source ↗ - News (RSS)zerohedge·4d ago·Neutral
Futures Rise Ahead Of Hot CPI As Houthis Torch Aramco HQ, ASML Beat Fails To Revive Chip Trade Futures Rise Ahead Of Hot CPI As Houthis Torch Aramco HQ, ASML Beat Fails To Revive Chip Trade US futures are higher, with small caps leading and tech lagging, as traders brace for what is expected to be the hottest monthly CPI print since the spring, digest more escalation in the Gulf after Yemen's Houthis hit Saudi Aramco's Dhahran headquarters and vowed more strikes on Saudi airports and oil facilit
View source ↗ - News (RSS)seekingalpha·4d ago·Neutral
TDV: I Changed My Mind; There Is A Better Option For Dividend Investors
View source ↗ - News (RSS)financialpost·5d ago·Neutral
Nordique Critical Metals Announces TSXV Final Approval for its Acquisition of Option to Earn Up to 80% Interest in the Kwyjibo Rare Earth Project in Québec; Files Amended 2026 Kwyjibo PEA Report MONTREAL, Oct. 13, 2026 (GLOBE NEWSWIRE) — Nordique Critical Metals Inc. (formerly, Consolidated Lithium Metals Inc.) (TSXV: NQC | FRA: J6K | OTCQB: JORFF) (“NQC” or the “Company”) is pleased to announce that it has received final approval from the TSX Venture Exchange (“TSXV”) for its previously announc
View source ↗ - Newsgurufocus.com·6d ago·Neutral
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders? Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene
View source ↗ - Newsprnewswire.com·6d ago·Neutral
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders? /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
View source ↗ - Newsbusinesswire.com·6d ago·Negative
OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $OPCH--OPCH Investors Have Opportunity to Join Option Care Health, Inc. Fraud Investigation with SBS Law.
View source ↗ - News (RSS)seekingalpha·8d ago·Neutral
Key deals this week: Option Care Health, PTC, Energy Transfer and more
View source ↗ - News (RSS)thestreet·11d ago·Neutral
Option Care stock surges on McKesson's home-infusion bet McKesson is taking 49% of Option Care as more complex infusion treatments shift to homes and outpatient sites.
View source ↗ - News (Marketaux)seekingalpha.com·11d ago·Positive
Option Care: Booking My Gains Ahead Of Deal Completion (NASDAQ:OPCH) I invested in Option Care</[+213 characters]
View source ↗ - News (RSS)seekingalpha·11d ago·Positive
Option Care: Booking My Gains Ahead Of Deal Completion
View source ↗ - Newszacks.com·11d ago·Neutral
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength? Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
View source ↗ - Newsfool.com·12d ago·Positive
Why Option Care Health Stock Skyrocketed on Tuesday Option Care is being bought out by McKesson and private equity firm Clayton Dubilier & Rice. The deal values Option Care at $32.05 per share or about $5.8 billion.
View source ↗ - Newsseekingalpha.com·33d ago·Positive
Option Care Health, Inc. (OPCH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Option Care Health, Inc. (OPCH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
Option Care Health to Participate in Upcoming Investor Conferences BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences:
View source ↗ - Newszacks.com·54d ago·Neutral
OPCH or CHE: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
View source ↗
Earnings
Wed, Nov 4(in 2 weeks)
Consensus estimate $0.49 per share
Typical surprise +5.6% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$0.45 vs $0.43beat
- Thu, Apr 30$0.40 vs $0.37beat
- Tue, Feb 24$0.46 vs $0.46beat
- Thu, Oct 30$0.45 vs $0.43beat
- Wed, Jul 30$0.41 vs $0.40beat
- Tue, Apr 29$0.40 vs $0.36beat
Estimates and results for OPCH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by OPCH officers and directors.
- Bought
- $4.5m
- Sold
- $2.2m
10 trades
3 trades
- Sullivan Timothy Pbought
- Kraemer Harry M Jansen Jrbought
- Sethna Meenalbought
- Rademacher John Charlesbought
- Pate R Cartersold
- Bavaro Michaelsold
- Kraemer Harry M Jansen Jrbought
- Wright Norman L.bought
87 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.